Initial dosage regimens of vancomycin for Chinese adult patients based on population pharmacokinetic analysis

被引:27
作者
Deng, Chenhui [1 ,2 ]
Liu, Taotao [3 ]
Zhou, Tianyan [1 ,2 ]
Lu, Hua [3 ]
Cheng, Daohai [3 ]
Zhong, Xiaobing [3 ]
Lu, Wei [1 ,2 ]
机构
[1] Peking Univ, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China
[2] Peking Univ, Sch Pharmaceut Sci, Beijing 100191, Peoples R China
[3] Guangxi Med Univ, Affiliated Hosp 1, Guangxi, Peoples R China
关键词
vancomycin; Chinese adult patients; population pharmacokinetics; NONMEM; steady-state trough concentrations; RESISTANT STAPHYLOCOCCUS-AUREUS; NEPHROTOXICITY; INFECTIONS; OUTCOMES;
D O I
10.5414/CP201842
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: To build a population pharmacokinetic model for Chinese adult patients and develop initial dosage regimens for patients with different degrees of renal function to achieve target steady-state trough concentrations in the range of 10 - 15 and 15 - 20 mg/l. Method: Data on serum vancomycin concentration was collected from a retrospective study including 72 Chinese adult patients. NON-MEM was used to build the population pharmacokinetic model, and a one-compartment model was chosen to describe the vancomycin concentration-time profile. Internal evaluation by bootstrap and visual predictive check (VPC) was performed to evaluate the robustness and prediction of the final model. Monte Carlo simulations were conducted to develop initial dosage regimens to achieve target trough concentrations. Results: A one-compartment model was built with creatinine clearance (CLcr) as the key covariate influencing drug clearance. The estimated drug clearance for patients with normal renal function (CLcr >= 80 ml/min) was 4.90 1/h, and 0.0654 x CLcr if CLcr was < 80 ml/min. The apparent volume of the central compartment was 47.76 1 and no covariate was found to affect it. The results of bootstrap analysis were in agreement with the original parameters of the final model, and VPC of the final model demonstrated good predictability. Initial dosage regimens were developed based on the simulations of the population pharmacokinetic model. Conclusion: A one-compartment model fitted the retrospective data and CLcr had a significant effect on drug clearance. Initial dosage regimens for vancomycin were proposed to provide some help to individual therapy for Chinese adult patients with different renal functions.
引用
收藏
页码:407 / 415
页数:9
相关论文
共 50 条
  • [21] Population Pharmacokinetic of Vancomycin Administered by Continuous Infusion in Critically Ill Patients
    Ben Romdhane, Haifa
    Woillard, Jean Baptiste
    Ben Fadhel, Najah
    Chadli, Zohra
    Chaabane, Amel
    Boughattas, Naceur
    Ben Fredj, Nadia
    Aouam, Karim
    PHARMACOLOGY, 2024,
  • [22] Development and validation of a population pharmacokinetic model of vancomycin for patients of advanced age
    Takada, Keisuke
    Samura, Masaru
    Igarashi, Yuki
    Suzuki, Ayako
    Ishigo, Tomoyuki
    Fujii, Satoshi
    Ibe, Yuta
    Yoshida, Hiroaki
    Tanaka, Hiroaki
    Ebihara, Fumiya
    Maruyama, Takumi
    Hamada, Yukihiro
    Komatsu, Toshiaki
    Tomizawa, Atsushi
    Takuma, Akitoshi
    Chiba, Hiroaki
    Yagi, Yusuke
    Nishi, Yoshifumi
    Enoki, Yuki
    Taguchi, Kazuaki
    Tanikawa, Koji
    Kunishima, Hiroyuki
    Matsumoto, Kazuaki
    JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES, 2025, 11 (01):
  • [23] Optimization of Micafungin Dosage for Chinese Patients with Sepsis in the Intensive Care Unit Based on a Population Pharmacokinetic-Pharmacodynamic Analysis
    Shubai Zhong
    Xu Zhu
    Limei Zhao
    Yan Song
    Jian Yu
    Zhen Zheng
    Bin Zang
    Pharmaceutical Research, 2021, 38 : 67 - 77
  • [24] Vancomycin Dosage Optimization in Patients with Malignant Haematological Disease by Pharmacokinetic/Pharmacodynamic Analysis
    del Mar Fernandez de Gatta, Maria
    Santos Buelga, Dolores
    Sanchez Navarro, Amparo
    Dominguez-Gil, Alfonso
    Jose Garcia, Maria
    CLINICAL PHARMACOKINETICS, 2009, 48 (04) : 273 - 280
  • [25] Optimization of Micafungin Dosage for Chinese Patients with Sepsis in the Intensive Care Unit Based on a Population Pharmacokinetic-Pharmacodynamic Analysis
    Zhong, Shubai
    Zhu, Xu
    Zhao, Limei
    Song, Yan
    Yu, Jian
    Zheng, Zhen
    Zang, Bin
    PHARMACEUTICAL RESEARCH, 2021, 38 (01) : 67 - 77
  • [26] Population pharmacokinetic analysis of vancomycin in pediatric continuous renal replacement therapy
    Brady S. Moffett
    Jennifer Morris
    Flor Munoz
    Ayse Akcan Arikan
    European Journal of Clinical Pharmacology, 2019, 75 : 1089 - 1097
  • [27] Population pharmacokinetic analysis of vancomycin in pediatric continuous renal replacement therapy
    Moffett, Brady S.
    Morris, Jennifer
    Munoz, Flor
    Arikan, Ayse Akcan
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 (08) : 1089 - 1097
  • [28] Population pharmacokinetic rationale for intravenous contezolid acefosamil followed by oral contezolid dosage regimens
    Bulitta, Jurgen B.
    Fang, Edward
    Stryjewski, Martin E.
    Wang, Wen
    Atiee, George J.
    Stark, Jeffrey G.
    Hafkin, Barry
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024, 68 (04)
  • [29] Vancomycin dosage optimization in pediatric patients with solid tumor disease by population pharmacokinetics analysis
    Guilhaumou, R.
    Marsot, A.
    Buffet-Delmas, P.
    Rome, A.
    Boulamery, A.
    Andre, N.
    Simon, N.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 : 70 - 71
  • [30] Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population
    Duong, Alexandre
    El Gamal, Ahmed
    Bilodeau, Veronique
    Huot, Justine
    Delorme, Carole
    Poudrette, Johanne
    Crevier, Benoit
    Marsot, Amelie
    PHARMACOTHERAPY, 2024, 44 (06): : 425 - 434